Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin

Nature

Volumn 456, Issue 7222, 2008, Pages 648-652

  Byres, Emma ^a   Paton, Adrienne W ^b   Paton, James C ^b   Löfling, Jonas C ^c   Smith, David F ^d   Wilce, Matthew C J ^a   Talbot, Ursula M ^b   Chong, Damien C ^b   Yu, Hai ^e   Huang, Shengshu ^e   Chen, Xi ^e   Varki, Nissi M ^c   Varki, Ajit ^c   Rossjohn, Jamie ^a   Beddoe, Travis ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c University of California San Diego   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; GLYCAN; MONOSACCHARIDE; N GLYCOLOYLNEURAMINIC ACID; PROTEIN SUBAB; UNCLASSIFIED DRUG;

BACTERIUM; CYTOLOGY; DIET; DIGESTIVE SYSTEM DISORDER; TOXICITY; TOXIN;

ARTICLE; BODY FLUID; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE EPITHELIUM; KIDNEY FUNCTION; MUTAGENESIS; PRIORITY JOURNAL; VASCULARIZATION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; EUKARYOTA; MUS;

EID: 57349192094     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature07428     Document Type: Article

References (30)

1. 5 cytotoxins produced by Shiga toxigenic Escherichia coli. J. Exp. Med. 200, 35-46 (2004).
2. Paton, J. C. & Paton, A. W. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 11, 450-479 (1998).
3. 5 toxin that targets the endoplasmic reticulum. J. Infect. Dis. 196, 1093-1101 (2007).
4. 5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP. Nature 443, 548-552 (2006).
5. Sandvig, K. & van Deurs, B. Membrane traffic exploited by protein toxins. Annu. Rev. Cell Dev. Biol. 18, 1-24 (2002).
6. Lencer, W. I. & Tsai, B. The intracellular voyage of cholera toxin: going retro. Trends Biochem. Sci. 28, 639-645 (2003).
7. Crocker, P. R., Paulson, J. C. & Varki, A. Siglecs and their roles in the immune system. Nature Rev. Immunol. 7, 55-66 (2007).
8. Neu, U., Woellner, K., Gauglitz, G. & Stehle, T. Structural basis of GM1 ganglioside recognition by simian virus 40. Proc. Natl Acad. Sci. USA 105, 5219-5224 (2008).
9. Murzin, A. G. OB (oligonucleotide/oligosaccharide binding)-fold: common structural and functional solution for non-homologous sequences. EMBO J. 12, 861-867 (1993).
10. Stein, P. E. et al. Structure of a pertussis toxin-sugar complex as a model for receptor binding. Nature Struct. Biol. 1, 591-596 (1994).
11. Merritt, E. A., Sixma, T. K., Kalk, K. H., van Zanten, B. A. & Hol, W. G. Galactose-binding site in Escherichia coli heat-labile enterotoxin (LT) and cholera toxin (CT). Mol. Microbiol. 13, 745-753 (1994).
12. Merritt, E. A. et al. Structural studies of receptor binding by cholera toxin mutants. Protein Sci. 6, 1516-1528 (1997).
13. Ling, H., Bast, D. & Brunton, J. L. &. R. e. a. d. R. J. Structure of the Shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry 37, 1777-1788 (1998).
14. Yahiro, K. et al. Identification and characterization of receptors for vacuolating activity of subtilase cytotoxin. Mol. Microbiol. 62, 480-490 (2006).
15. Hedlund, M. et al. N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution. Mol. Cell. Biol. 27, 4340-4346 (2007).
16. Varki, A. Multiple changes in sialic acid biology during human evolution. Glycoconjugate J. doi:10.1007/s10719-008-9183-z (7 September 2008).
17. Tangvoranuntakul, P. et al. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc. Natl Acad. Sci. USA 100, 12045-12050 (2003).
18. Gagneux, P. et al. Proteomic comparison of human and great ape blood plasma reveals conserved glycosylation and differences in thyroid hormone metabolism. Am. J. Phys. Anthropol. 115, 99-109 (2001).
19. Talbot, U. M., Paton, J. C. & Paton, A. W. Protective immunization of mice with an active-site mutant of subtilase cytotoxin of Shiga toxin-producing Escherichia coli. Infect. Immun. 73, 4432-4436 (2005).
20. 5 toxin that targets the ER chaperone BiP. Cell. Microbiol. 10, 795-806 (2008).
21. Leslie, A. G. W. in Joint CCP4 and ESF-EACMB Newsletter on Protein Crystallography 26 (SERC, 1992).
22. Evans, P. R. in Proc. CCP4 Study Weekend on Recent Advances in Phasing 97-102 (CCLRC, 1997).
23. Collaborative Computational Project. Number 4. Acta Crystallogr. D 50, 760-763 (1994).
24. Adams, P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D 58, 1948-1954 (2002).
25. Terwilliger, T. C. Automated main-chain model building by template matching and iterative fragment extension. Acta Crystallogr. D 59, 38-44 (2003).
26. Perrakis, A., Sixma, T. K., Wilson, K. S. & Lamzin, V. S. Warp: improvement and extension of crystallographic phases by weighted averaging of multiple refined dummy models. Acta Crystallogr. D 30, 551-554 (1997).
27. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126-2132 (2004).
28. Murshodov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum likelihood method. Acta Crystallogr. D 53, 240-255 (1997).
29. McCoy, A. J., Grosse-Kunstleve, R. W., Storoni, L. C. & Read, R. J. Likelihood-enhanced fast translation functions. Acta Crystallogr. D 61, 458-464 (2005).
30. Schuettelkopf, A. W. & van Aalten, D. M. F. PRODRG - a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D 60, 1355-1363 (2004).